Factors that may affect the response of onychomycosis to oral antifungal therapy
- 1 November 1998
- journal article
- review article
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 39 (4) , 222-224
- https://doi.org/10.1111/j.1440-0960.1998.tb01477.x
Abstract
With the advent of the newer oral antifungals available to treat onychomycosis, the majority of patients respond to therapy. However, there may be subsets of patients who exhibit poor response or failure. Possible explanations for this may be grouped into categories, including: (i) patient characteristics; (ii) organisms causing or associated with the nail infection; (iii) nail characteristics; and (iv) local diseases involving the nail.Keywords
This publication has 20 references indexed in Scilit:
- Bacterial infection in a patient with onychomycosisJournal of the American Academy of Dermatology, 1997
- Guidelines of care for dermatologic conditions in patients infected with HIVJournal of the American Academy of Dermatology, 1997
- A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre studyBritish Journal of Dermatology, 1997
- A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre studyBritish Journal of Dermatology, 1997
- Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrumJournal of the American Academy of Dermatology, 1996
- Immune response and host resistance of humans to dermatophyte infectionJournal of the American Academy of Dermatology, 1993
- Progression of interdigital infections from simplex to complexJournal of the American Academy of Dermatology, 1993
- Interdigital athlete's foot. The interaction of dermatophytes and resident bacteriaArchives of Dermatology, 1978
- Immune responses in patients with chronic Trichophyton rubrum infectionsClinical and Experimental Dermatology, 1977